This document provides an overview of pain management and opioid use for cancer patients. It discusses how cancer pain is common and should be properly assessed and treated. The WHO pain ladder is reviewed as the standard approach for treating pain with non-opioids, weak opioids, and strong opioids. Opioid rotation and treating pain crises are covered, including calculating opioid conversions and administering parenteral opioids. Challenges in treating cancer pain in patients with addiction histories are addressed through transparency, long-acting opioids, and pain contracts. Overall guidelines aim to properly treat pain while avoiding exacerbating addiction issues.
CME presentation made on 10th Nov 2012. Discusses a Radiation Oncologist's perspectives of cancer pain management, shortcomings of WHO pain ladder, ASTRO guidelines for metastatic bone pain.
CME presentation made on 10th Nov 2012. Discusses a Radiation Oncologist's perspectives of cancer pain management, shortcomings of WHO pain ladder, ASTRO guidelines for metastatic bone pain.
a detailed description of pain and therpaeutic options available and clinical assessment of pain, approach to the patient with pain, assessment of intensity of pain, nsaids and opioids, tca. WHO pain ladder, chronic opioid therapy
It is an oncologic emergency. This slides contains a brief discussion on mechanism of spinal cord compression , common malignancies presenting with spinal cord compression , approach to a patient with cord compression like features and management this catastrophic situation.
a detailed description of pain and therpaeutic options available and clinical assessment of pain, approach to the patient with pain, assessment of intensity of pain, nsaids and opioids, tca. WHO pain ladder, chronic opioid therapy
It is an oncologic emergency. This slides contains a brief discussion on mechanism of spinal cord compression , common malignancies presenting with spinal cord compression , approach to a patient with cord compression like features and management this catastrophic situation.
For more information:
http://www.7activestudio.com
info@7activestudio.com
http://www.7activemedical.com/
info@7activemedical.com
http://www.sciencetuts.com/
Contact: +91- 9700061777,
040-64501777 / 65864777
7 Active Technology Solutions Pvt.Ltd. is an educational 3D digital content provider for K-12. We also customise the content as per your requirement for companies platform providers colleges etc . 7 Active driving force "The Joy of Happy Learning" -- is what makes difference from other digital content providers. We consider Student needs, Lecturer needs and College needs in designing the 3D & 2D Animated Video Lectures. We are carrying a huge 3D Digital Library ready to use.
Clossing
By 3 step ladder WHO cancer pain management, 90 % of cancer pain can be relief.
Since cancer patients cannot be cured, our main task is to let them die free of pain with Iman
opioids in cancer pain manage, a case-based approach, covering
- opioid dosing and rotations
- pain assessment
- opioids adverse effects and managment thereof
- overcoming barriers to usage
Ems world expo pain management 11112014.handoutMichael Dailey
Acute pain management is one of the keys to quality patient care. Over the course of the last 10 years there has been a steady evolution of prehospital pain management protocols and use of different medications. Currently, we are on the verge of a national standard of care for treatment of pain in ambulances. What has changed over that time? What medications are currently being used across the country? How are these medications being given? Dr. Dailey will discuss a national dataset of pain management protocols and discuss the goals for optimal pain management for the acute pain of medical or traumatic pain in the prehospital arena.
A lecture given to nurse practitioners, physician assistants and others on pain management. The aim of the talk is to review:
1- the principles of effective pain management;
2- the knowledge and/or resources to assist in indentifying patients at high risk for substance abuse, and
3- the importance of counseling patients about the side effects, addictive nature and proper storage and disposal of prescription medications.
*Disclaimer: Case presentation is made up of a combination of cases, and does not reflect the case of any one particular patient.
More from iPall: UMass Medical School Palliative Care (7)
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
1. Pain Management & Opioid Use for
the
Cancer Patient
Suzana Makowski, MD MMM
Co-Chief of Palliative Care
Brenda Neil, NP
Palliative Care Nurse Practitioner
UMass Memorial Healthcare
2. The obligation of physicians
to relieve suffering stretches
back to antiquity.
[However, there is] a
modern paradox: Even in the
best settings and with the
best physicians, it is not
uncommon for suffering to
occur not only during the
course of a disease, but also
as a result of its treatment.
-Eric Cassell, MD
4. Cancer Pain - Reported
1of 3 patients with active cancer
3 of 4 patients with advanced cancer
5. Questions to keep in mind
• Intensity
• Etiology of pain
– Tumor burden (and location)
– Drug induced
• Quality of pain
• Time-line patter of pain
• What has been tried before (helped or not)
6. Time-course of cancer pain
Generally:
– Constant pain with breakthrough periods
Rarely:
– True incident pain (movement only)
– Tougher to treat – recommend pain specialist or
palliative care specialist to evaluate.
• May need intervention (intrathecal pain pump), radiation,
etc.
10. Principles of Opioid Pharmacology
Time to max effect (cmax)
For prn dosing
Half-life (t½)
For scheduled dosing
PO/PR 40-60 minutes 4 hours
SQ/IM 20 minutes 3-4 hours
IV 6-12 minutes (depending on opioid) 3-4 hours
Does not apply to methadoneDoes not apply to methadone
13. Case of Hector G. – part 1
• 56 yo Puerto Rican gentleman with metastatic
prostate cancer to bone. s/p radiation,
undergoing chemotherapy and hormone
therapy.
• Medications:
– Percocet 5/320 mg 1-2 tabs q4 hours prn
– Senna and colace
• Comes to visit for increased pain – ran out of
medications
14. Case of Hector G. – part 1
• Prescribe long-acting and short-acting.
– Why?
– How to calculate?
– Which medications?
Step 1: Calculate 24 hour dose of current opioid use
Hector is taking on 12 tablets of Percocet per day
= 60mg oxycodone + 3900mg acetaminophen per day
Which medication total is
more concerning?
15.
16. Case of Hector G. – part 1
• Prescribe long-acting and short-
acting.
– Why?
– How to calculate?
– Which medications?
Step 2: Convert 24 hour current opioid to new opioid (or
stay with current opioid) and calculate long acting dose
60mg oxycodone = Oxycontin 30mg bid OR
60mg x (15 morphine/10 oxycodone)= Morphine ER 45mg
bid
Step 3: if starting new opioid, consider adjusting for
cross-tolerance:
17. Case of Hector G. – part 1
• Prescribe long-acting and short-acting.
– Why?
– How to calculate?
– Which medications?
Step 3: Calculate breakthrough dose based on 10-20% of
daily long-acting
60mg oxycodone ER oxycodone IR 5-10mg prn
60mg morphine ER morphine IR 7.5-15mg prn
Frequency: q2 hours prn – up to 6 doses per day
Morphine IR 15mg, ½-1 tab q2 hours prn, up to 6 doses per day #180 (perhaps #120)
If patient requires more
than 6 doses in 24 hours,
they should call
18. Case of Hector G – part 2
more calculations
1. Hector is admitted to hospital and is made
NPO.
• How do you convert his opioid to IV?
1. Hector’s cancer progresses, he is now in renal
failure with urine output less than 100ml per
day. He does not wish dialysis or IV fluids.
• What do you convert him to and why?
• What if he is NPO?
• What if he cannot have IV or SQ access?
Answers are in separate handoutAnswers are in separate handout
19. Pain Crisis
“This is as much of a crisis as a code” – Natalie Moryl
MD
http://jama.ama-assn.org/content/299/12/1457.full.pdf
21. Assess Pain Crisis
• Keep in mind emergencies and their associated symptoms:
– cord compression, hypercalcemia, opioid neurotoxicity, acute abdomen,
etc.
• What medications has the patient tried so far? How much?
Intensity • quality • timeline • associated symptoms • medications tried • other changes to painIntensity • quality • timeline • associated symptoms • medications tried • other changes to pain
22. Treat Pain Crisis “Pain Code”
• Parenteral opioids are best for crisis
• Convert all of last 24 hours into continuous IV
• To get pain under control
– Double highest home regimen PRN dose and convert to IV as starting
point
– Then provide doses based on time to max effect (approximately 10
minutes) until patient is comfortable. Prescriber should stay at bedside.
– If first dose has no effect, double it with next dose.
• Monitoring patient
– Pain intensity scale • sedation scale • respiratory rate/O2 Sat
• Once pain is controlled
– PCA or nurse boluses
– Anticipate conversion to non-parenteral regimen
23. Treat Pain Crisis
• Adjunct Therapies to consider:
– Steroids (dexamethasone for bone pain, tumor burden)
– Radiation therapy may be helpful
– Interventional pain/radiology for nerve blocks
– Aggressive adjust therapies that specialists may employ
include lidocaine or ketamine drips, epidural drips, etc.
– Non-pharmacologic interventions: cool or heat
therapy, touch, etc.
24. Engage and Support in Pain Crisis
• Nursing and Pharmacy colleagues
• Social work and chaplaincy
• Family
• Outside agencies – hospice may be helpful
25. At end of life…
CMO ≠ Continuous Morphine Only
Treat pain and other symptoms
Assess for side effects of therapies
Watch urine output if on continuous or long-acting opioid (other than fentanyl)
Treat pain and other symptoms
Assess for side effects of therapies
Watch urine output if on continuous or long-acting opioid (other than fentanyl)
27. Tending to the Addict’s Pain
MH
63 yo disabled woman with
metastatic breast cancer
Severe pain due to brachial
plexopathy
History of smoking and
addiction – high opioid
tolerance
LS
53 yo disabled woman with
metastatic lung cancer.
Pain is due to bone metastases
History of addiction
Current smoker
Tx:
Methadone 60mg TID, Fentanyl
patch 100mcg/hour, Morphine 90
mg q2 hours prn up to 5 times per
day
Tx:
Fentanyl patch 25mcg/hour,
Oxycodone 10mg q4 hours prn up
to 5 times per day
28. Tending to the Addict’s Cancer
Pain
• Function is key
• Transparency is key (being explicit)
– “I am here to care for you: take care of you pain
and not feed your addiction.”
• Aim to utilize principally long-acting opioids,
minimize short-acting
• Pain contract
• Ongoing request for more short-acting
without increase of long-acting is concern
Potential diversion
29. Tending to the Addict’s Cancer
Pain
• Inpatient principles:
– PCA is a good test
• Does function increase or decrease?
– Tolerance to opioids will be high, requirement will
likely be high
– Partner with patient, nursing, social work,
pharmacy
– Set clear goals (mutually determined)
30. TJ
53 yo ex-pro football
player, heroin addict on
methadone x 20+ years
Admitted with pain crisis
Treatment:
Hydromorphone gtt 40mg/hour
Methadone 30mg IVP q8 hours (then
switch to ketamine gtt)
Lidocaine gtt 20mg/kg/hour
PRN:
Hydromorphone 10mg IVP q30 min prn
33. Thank you
Suzana Makowski, MD:
Suzana.makowski@umassmemorial.org
Office: Debbie Horgan – (508) 344-8630
Delila Katz, PharmD:
Delila.katz@umassmemorial.org
New cancer center pharmacy
Editor's Notes
Common causes:
Bone and visceral mets
Immobility
Neuropathic pain
Soft tissue/muscle cramps
Constipation
Esophagitis/mucositis
Lymphedema
Chronic post-op scars
Adapted from Twycross R, Harcourt J, Bergl S: A survey of pain in patients with advanced cancer. J Pain Symptom Manage 1996;12:273-282.